Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

Employees

Sector

Biotechnology & Medical Research

Calendar

20/08 Earnings release - Q2 2026

More about the company

Market Cap	14Cr 1.43Cr 1.24Cr 1.15Cr 1.06Cr 2Cr 136.14Cr 2.03Cr 5.34Cr 68Cr 5.36Cr 5.24Cr 227.27Cr	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	14Cr 1.43Cr 1.24Cr 1.15Cr 1.06Cr 2Cr 136.14Cr 2.03Cr 5.34Cr 68Cr 5.36Cr 5.24Cr 227.27Cr	EV / Sales 2026 *	-	EV / Sales 2027 *	-
Free-Float	81.52%	Yield 2026 *	-	Yield 2027 *	-

25/07	Active Biotech Doses First Patient in Amended Ho172 Clinical Study of Tasquinimod in Myelofibrosis	CI
24/07	Active Biotech Doses First Patient in Amended Tasquinimod Myelofibrosis Trial	MT
24/07	Active Biotech doses first patient in updated tasquinimod study	FW
07/06	Certain Shares of Active Biotech AB are subject to a Lock-Up Agreement Ending on 7-JUN-2026.	CI
01/04	Active Biotech AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2025	CI

24/07	First patient dosed in the amended HO172 clinical study of tasquinimod in myelofibrosis	AQ
30/06	Number of shares and votes in Active Biotech	AQ

Manager	Title	Age	Since
Helén Tuvesson CEO	Chief Executive Officer	64	01/07/2017
Hans Kolam DFI	Director of Finance/CFO	75	01/01/2000
Erik Vahtola CTO	Chief Tech/Sci/R&D Officer	-	01/01/2022

Director	Title	Age	Since
Karl Peter Thelin BRD	Director/Board Member	70	07/04/2011
Michael Shalmi CHM	Chairman	61	23/05/2019
Uli Alf Hacksell BRD	Director/Board Member	76	23/05/2019

Active Biotech AB Share Price Other OTC

Stocks

Biotechnology & Medical Research

Valuation: Active Biotech AB

Latest news : Active Biotech AB

Press Releases: Active Biotech AB

Managers and Directors: Active Biotech AB

Bio Therapeutic Drugs

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACTIVE BIOTECH AB	-.--%	-.--%	-	-	1.43Cr
WUXI APPTEC CO., LTD.	+2.35%	+2.74%	+33.41%	+79.20%	5.65TCr
ARGENX SE	-0.21%	-7.38%	+25.34%	+63.02%	5.36TCr
BIONTECH SE	-2.44%	+1.40%	-15.74%	-16.80%	2.29TCr
INSMED INCORPORATED	-2.85%	-7.78%	-8.09%	+346.36%	2.14TCr
WUXI BIOLOGICS (CAYMAN) INC.	+2.49%	-0.92%	+20.31%	-12.15%	2.03TCr
GENMAB A/S	+0.79%	-1.06%	+29.29%	-33.32%	1.76TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.58%	-5.88%	+16.30%	+540.37%	1.47TCr
EXELIXIS, INC.	-5.25%	-4.23%	+46.41%	+169.05%	1.33TCr
PHARMAESSENTIA CORPORATION	+3.41%	-6.61%	+163.08%	+280.43%	1.35TCr
Average	-0.11%	-3.79%	+34.48%	+157.35%	2.6TCr
Weighted average by Cap.	+0.23%	-2.96%	+28.67%	+119.98%

	2026 *	2027 *
Net sales	-	-
Net income	-3.32Cr -34.81L -30.26L -28.17L -25.86L -48.83L -33Cr -49.59L -1.3Cr -17Cr -1.31Cr -1.28Cr -55Cr	1.82Cr 19.08L 16.59L 15.44L 14.18L 26.77L 18Cr 27.18L 71.43L 9.07Cr 71.67L 70.09L 30Cr
Net Debt	-	-